Sign In
Buy AVGR
$0.474
+0 (+0%)
At Close: May 13, 2025
Avinger to Announce Third Quarter 2022 Results on November 9
07:45am, Tuesday, 01'st Nov 2022
REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system
Avinger to Present at LD Micro Investor Conference
08:00am, Wednesday, 19'th Oct 2022
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, cathet
Avinger, Inc.'s (AVGR) CEO Jeff Soinski on Q2 2022 Results - Earnings Call Transcript
06:49pm, Friday, 12'th Aug 2022
Avinger, Inc. (NASDAQ:AVGR ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Jeff Soinski – Chief Executive Officer Nabeel Subainat
Avinger to Announce Second Quarter 2022 Results on August 11
08:00am, Friday, 05'th Aug 2022
REDWOOD CITY, CA / ACCESSWIRE / August 5, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f
Avinger, Inc. (AVGR) CEO Jeffery M. Soinski on Q1 2022 - Earnings Call Transcript
09:10pm, Tuesday, 10'th May 2022
Avinger, Inc. (NASDAQ:AVGR ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Jeffery M. Soinski – Chief Executive Officer Mark Weinswig – Chief Financial Officer Matt
Avinger (AVGR) Reports Q1 Loss, Misses Revenue Estimates
07:34pm, Tuesday, 10'th May 2022
Avinger (AVGR) delivered earnings and revenue surprises of -92.56% and 0.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avinger to Announce First Quarter 2022 Results on May 10
09:00am, Friday, 29'th Apr 2022
REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for
Avinger (AVGR) Reports Q4 Loss, Tops Revenue Estimates
06:48pm, Tuesday, 22'nd Mar 2022
Avinger (AVGR) delivered earnings and revenue surprises of 0% and 4.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avinger, Inc.'s (AVGR) CEO Jeff Soinski on Q4 2021 Results - Earnings Call Transcript
06:30pm, Tuesday, 22'nd Mar 2022
Avinger, Inc.'s (AVGR) CEO Jeff Soinski on Q4 2021 Results - Earnings Call Transcript
Avinger Registers 12% Decline In Q4 Revenue, Says Hospital Constraints Impacted Q4
05:02pm, Tuesday, 22'nd Mar 2022
Avinger Inc (NASDAQ: AVGR) reported a fourth-quarter revenue decrease of 12% year-over-year to $2.40 million, beating the consensus of $2.29 million. Hospital constraints impacted Q4 on procedural
Top Penny Stocks To Buy Right Now? 4 Short Squeeze Stocks To Watch
02:03pm, Friday, 18'th Mar 2022
Short squeeze penny stocks to watch right now. The post Top Penny Stocks To Buy Right Now?
Thinking about buying stock in Hycroft Mining, Excellon Resources, Avinger, Pearson, or Arcadia Biosciences?
12:35pm, Tuesday, 15'th Mar 2022 Benzinga
NEW YORK , March 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HYMC, EXN, AVGR, PSO, and RKDA. … Full story available on Benzinga.com
GME, BFLY and AVGR among pre market gainers
12:31pm, Tuesday, 15'th Mar 2022 Seeking Alpha
Hycroft Mining HYMC +84% AMC Entertainment is buying 22% of Hycroft Mining Holding.Incannex Healthcare (IXHL) +66%. Excellon Resources (EXN) +23%
Avinger to Announce Full-Year 2021 Results on March 22
07:30am, Tuesday, 15'th Mar 2022
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for
Avinger stock slips on 1-for-20 reverse stock split announcement
12:37pm, Monday, 14'th Mar 2022 Seeking Alpha
Avinger (AVGR) has slumped 9.17% pre-market after the medical device firm announced that it will implement a 1-for-20 reverse stock split of its common stock, effective 5:00 p.m. ET on Mar
